MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U-SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U-SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.
More...